1. 317 Comparative risk of venous thromboembolism (VTE) among patients with atopic dermatitis (AD) or other immune-mediated diseases: a cohort study using United States claims data. (25th January 2023) Authors: Merola, Joseph F; Danwada, Raghava; Ertmer, Brennan; Liang, Huifang; Ofori, Sarah; Krueger, Whitney Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 332 Improvement in symptoms of atopic dermatitis (AD) and AD-related quality of life with dupilumab treatment in adults: 24-week results of the DUPISTAD study. (25th January 2023) Authors: Merola, Joseph F; Chiou, Albert S; During, Emmanuel; Costanzo, Antonio; Foley, Peter; Ardeleanu, Marius; Wu, Jiangming; Ozturk, Zafer E Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment. (25th January 2023) Authors: Merola, Joseph F; Chiou, Albert S; During, Emmanuel; Costanzo, Antonio; Foley, Peter; Ardeleanu, Marius; Wu, Jiangming; Ozturk, Zafer E Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE). Issue 10370 (7th January 2023) Authors: Merola, Joseph F; Landewé, Robert; McInnes, Iain B; Mease, Philip J; Ritchlin, Christopher T; Tanaka, Yoshiya; Asahina, Akihiko; Behrens, Frank; Gladman, Dafna D; Gossec, Laure; Gottlieb, Alice B; Thaçi, Diamant; Warren, Richard B; Ink, Barbara; Assudani, Deepak; Bajracharya, Rajan; Shende, Vishv... Journal: Lancet Issue: Volume 401:Issue 10370(2023) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial. Issue 10222 (8th February 2020) Authors: Ritchlin, Christopher T; Kavanaugh, Arthur; Merola, Joseph F; Schett, Georg; Scher, Jose U; Warren, Richard B; Gottlieb, Alice B; Assudani, Deepak; Bedford-Rice, Kathy; Coarse, Jason; Ink, Barbara; McInnes, Iain B Journal: Lancet Issue: Volume 395:Issue 10222(2019) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Issue 10370 (7th January 2023) Authors: McInnes, Iain B; Asahina, Akihiko; Coates, Laura C; Landewé, Robert; Merola, Joseph F; Ritchlin, Christopher T; Tanaka, Yoshiya; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Assudani, Deepak; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Mease, Philip J Journal: Lancet Issue: Volume 401:Issue 10370(2023) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial. Issue 10273 (6th February 2021) Authors: Reich, Kristian; Papp, Kim A; Blauvelt, Andrew; Langley, Richard G; Armstrong, April; Warren, Richard B; Gordon, Kenneth B; Merola, Joseph F; Okubo, Yukari; Madden, Cynthia; Wang, Maggie; Cioffi, Christopher; Vanvoorden, Veerle; Lebwohl, Mark Journal: Lancet Issue: Volume 397:Issue 10273(2021) Page Start: 487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study. Issue 3 (2nd November 2021) Authors: Skougaard, Marie; Jørgensen, Tanja S; Jensen, Mia J; Ballegaard, Christine; Guldberg-Møller, Jørgen; Egeberg, Alexander; Christensen, Robin; Benzin, Peter; Stisen, Zara R; Merola, Joseph F; Coates, Laura C; Strand, Vibeke; Mease, Phillip; Kristensen, Lars Erik Journal: Rheumatology advances in practice Issue: Volume 5:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need. Issue 1 (27th December 2021) Authors: Guo, Lisa N; Perez-Chada, Lourdes M; Borucki, Robert; Nambudiri, Vinod E; Werth, Victoria P; Merola, Joseph F Journal: Lupus science & medicine Issue: Volume 8:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Distinguishing rheumatoid arthritis from psoriatic arthritis. Issue 2 (13th August 2018) Authors: Merola, Joseph F; Espinoza, Luis R; Fleischmann, Roy Journal: RMD open Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗